Cancer chemotherapy update - CapIri (XelIri) regimen for advanced and metastatic colorectal or esophogastric cancer

M. R. Rutledge, Dominic A. Solimando, James Waddell

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)98-105
Number of pages8
JournalHospital Pharmacy
Volume47
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Drug Therapy
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacy

Cite this

Cancer chemotherapy update - CapIri (XelIri) regimen for advanced and metastatic colorectal or esophogastric cancer. / Rutledge, M. R.; Solimando, Dominic A.; Waddell, James.

In: Hospital Pharmacy, Vol. 47, No. 2, 01.02.2012, p. 98-105.

Research output: Contribution to journalArticle

@article{c685b9b748ef4488bf96aca4882cf629,
title = "Cancer chemotherapy update - CapIri (XelIri) regimen for advanced and metastatic colorectal or esophogastric cancer",
author = "Rutledge, {M. R.} and Solimando, {Dominic A.} and James Waddell",
year = "2012",
month = "2",
day = "1",
doi = "10.1310/hpj4702-98",
language = "English (US)",
volume = "47",
pages = "98--105",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "2",

}

TY - JOUR

T1 - Cancer chemotherapy update - CapIri (XelIri) regimen for advanced and metastatic colorectal or esophogastric cancer

AU - Rutledge, M. R.

AU - Solimando, Dominic A.

AU - Waddell, James

PY - 2012/2/1

Y1 - 2012/2/1

UR - http://www.scopus.com/inward/record.url?scp=84857009263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857009263&partnerID=8YFLogxK

U2 - 10.1310/hpj4702-98

DO - 10.1310/hpj4702-98

M3 - Article

VL - 47

SP - 98

EP - 105

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 2

ER -